Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,820 $ 7,396
Accounts receivable, net 2,572 2,407
Inventories, net 2,858 2,663
Prepaid expenses and other current assets 4,308 3,746
Current portion of deferred consideration, net of discount 240 218
Total current assets 13,798 16,430
Property and equipment, net 488 320
Operating lease, right of use assets 418 559
Deferred tax asset 949 829
Deferred consideration, net of discount, less current portion 505 630
Other assets 73 77
Total assets 16,231 18,845
Current liabilities:    
Accounts payable 841 1,641
Accrued expenses and other current liabilities 2,029 1,843
Deferred revenue 100 1,223
Deferred revenue Invekra 60 54
Current portion of debt-PPP 0 120
Short-term debt 431 688
Operating lease liabilities 256 250
Total current liabilities 3,717 5,819
Deferred revenue Invekra, net of current portion 140 182
Withholding tax payable 4,235 3,838
Operating lease liabilities, less current portion 162 309
Total liabilities 8,254 10,148
Commitments and Contingencies (Note 11)
Stockholders’ Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at March 31, 2023 and 2022, respectively, no shares issued and outstanding at March 31, 2023 and 2022, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at March 31, 2023 and 2022, respectively, 4,933,550 and 3,100,937 shares issued and outstanding at March 31, 2023 and 2022, respectively (Note 12) 5 2
Additional paid-in capital 200,904 197,370
Accumulated deficit (189,514) (184,363)
Accumulated other comprehensive loss (3,418) (4,312)
Total stockholders’ equity 7,977 8,697
Total liabilities and stockholders’ equity $ 16,231 $ 18,845